A recent study reported transcriptional reprogramming in BRCA1-deficient ovarian cancer cells, which leads to cell-intrinsic inflammation through activation of stimulator of IFN genes (STING; ref. 56). This evidence concerns the gene BRCA1 and ovarian cancer.